市场调查报告书
商品编码
1298646
临床试验管理系统市场:2023-2028年全球行业趋势、份额、规模、增长、机会及预测Clinical Trial Management Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球临床试验管理系统市场规模达到10.331亿美元。展望未来,IMARC集团预计到2028年,全球临床试验管理系统市场规模将达到19.534亿美元,2023-2028年的年均复合增长率(CAGR)将达到11%。对高效临床试验的需求不断增长、监管机构为确保符合法规而施加的压力不断增加以及广泛的研发活动是推动市场发展的一些关键因素。
临床试验管理系统(CTMS)是计算机操作的软件系统,广泛用于简化临床试验流程。它们旨在帮助公司更有效地管理临床试验,降低成本,并保持试验结果的质量和安全性。这些系统的模块包括跟踪患者数据、管理临床试验文件、跟踪临床试验活动、安排预约以及管理临床试验机构与申办者之间的沟通。它们还提供各种报告和分析选项,帮助企业更好地了解临床试验绩效并做出明智决策。它们帮助企业更好地管理临床试验,同时确保临床试验结果的最高质量和安全性。由于临床试验的复杂性不断增加,全球对临床试验管理系统的需求也大幅增长。
高效临床试验需求的不断增长是全球市场的主要驱动力。此外,许多制药和生物技术公司正致力于提高其临床试验的效率,以降低成本并加快新疗法的开发,这为市场提供了推动力。由于临床试验管理系统有助于简化临床试验流程、减少错误数量并提高整体数据准确性,因此推动了全球市场的需求。随着临床试验管理系统的广泛应用,患者可以访问自己的数据,了解自己的数据在临床试验中的使用情况,从而提高了患者的参与度,这对市场产生了有利影响。此外,监管机构为确保符合法规要求而施加的压力也对市场产生了积极影响。因此,临床试验管理系统可帮助企业确保以高效、低成本的方式满足数据收集和报告等所有监管要求,这也是另一个促进增长的因素。此外,越来越多的企业采用CTMS来促进医疗机构和研究团队之间的合作,以开展有效的临床试验,这也创造了积极的市场前景。推动市场发展的其他因素还包括技术的不断进步和医疗基础设施的持续改善。
The global clinical trial management systems market size reached US$ 1,033.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,953.4 Million by 2028, exhibiting a growth rate (CAGR) of 11% during 2023-2028. The growing demand for efficient clinical trials, rising pressure from regulatory agencies to ensure compliance with regulations, and extensive research and development activities represent some of the key factors driving the market.
Clinical trial management systems (CTMS) are computer-operated software systems that are widely utilized to streamline the clinical trial process. They are designed to help companies manage their clinical trials more efficiently by reducing costs and maintaining the quality and safety of the trial results. They have modules for tracking patient data, managing clinical trial documents, tracking clinical trial activities, scheduling appointments, and managing communication between clinical trial sites and sponsors. They also provide a variety of reports and analytics options to assist companies in better understanding the clinical trial performance and making informed decisions. They aid companies in better managing their clinical trials while ensuring the clinical trial results are of the highest quality and safety. Due to the increasing complexities in clinical trials, there has been a considerable increase in the demand for clinical trial management systems across the globe.
The escalating demand for efficient clinical trials majorly drives the global market. Additionally, numerous pharmaceutical and biotechnology companies are focusing on improving the efficiency of their clinical trials, in order to reduce costs and speed up the development of new treatments, which is providing a boost to the market. Since, clinical trial management systems help to streamline clinical trial processes, reduce the number of errors, and improve overall data accuracy, are propelling demand on the global level. With the widespread adoption of clinical trial management systems with a view to enhancing patient engagement by providing patients with access to their data and allowing them to see how their data is being used in the clinical trial is impacting the market favorably. Along with this, the rising pressure from regulatory agencies to ensure compliance with regulations is also positively influencing the market. In line with this, clinical trial management systems help organizations to ensure that they meet all regulatory requirements, such as data collection and reporting, efficiently and cost-effectively, which is acting as another growth-inducing factor. Furthermore, the growing adoption of CTMS to facilitate collaboration between healthcare organizations and research teams for effective clinical trials is creating a positive market outlook. Some of the other factors driving the market include continual technological advancements and continual improvements in healthcare infrastructure.
IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical trial management systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, deployment mode and end user.
Software
Services
The report has provided a detailed breakup and analysis of the clinical trial management systems market based on the component. This includes software and services. According to the report, software is dominating the total market share.
Web-based CTMS
On-premise
Cloud-based CTMS
A detailed breakup and analysis of the clinical trial management systems market based on the deployment mode have also been provided in the report. This includes web-based CTMS, on-premise, and cloud-based CTMS. According to the report, web-based CTMS accounted for the largest market.
Pharmaceutical and Biotechnology Firms
Contract Research Organizations
Others
The report has provided a detailed breakup and analysis of the clinical trial management systems market based on the component. This includes pharmaceutical and biotechnology firms, contract research organizations, and others. according to the report, pharmaceutical and biotechnology firms represent the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America holds the leading position in the market for clinical trial management systems. Some of the factors driving the North America clinical trial management systems market included continual technological advancements and the presence of large players.
The report has also provided a comprehensive analysis of the competitive landscape in the global clinical trial management systems market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Advarra Inc., ArisGlobal LLC, BioClinica Inc., DataTrak International Inc., DZS Clinical Services Inc. (WDB Holdings Co. Ltd.), International Business Machines Corporation, Medidata Solutions Inc. (Dassault Systemes SE), MedNet Solutions Inc., Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC and Veeva Systems Inc.
Key Questions Answered in This Report
1. What was the size of the global clinical trial management systems market in 2022?
2. What is the expected growth rate of the global clinical trial management systems market during 2023-2028?
3. What has been the impact of COVID-19 on the global clinical trial management systems market?
4. What are the key factors driving the global clinical trial management systems market?
5. What is the breakup of the global clinical trial management systems market based on the component?
6. What is the breakup of the global clinical trial management systems market based on the deployment mode?
7. What is the breakup of the global clinical trial management systems market based on the end user?
8. What are the key regions in the global clinical trial management systems market?
9. Who are the key players/companies in the global clinical trial management systems market?